Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930969 · ClinicalTrials.gov registry record
ST Segment Detection Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- 175
- Enrollment target
NCT00930969: Clinical Trial study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00930969 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00930969 was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- 175 participants
- Enrollment target
Study Summary
The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) who have coronary artery disease.
Primary Outcome
The primary objective of the study was to observe if there are any detectable ST segment changes on an electrogram (EGM) signal from an implanted cardiac defibrillator (ICD) during myocardial infarctions among study participants.
Interventions
- DEVICE ICD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-03 |
Why NCT00930969 stopped before completion
NCT00930969 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ICD is the first listed.
NCT00930969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00930969 about?
NCT00930969 is a clinical study titled "ST Segment Detection Study". The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) wh...
What is the current status of trial NCT00930969?
This trial is currently terminated. The enrollment target is 175 participants. The study started on 2008-04. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00930969?
The interventions under investigation include: ICD (DEVICE).
Who is sponsoring clinical trial NCT00930969?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia